» Articles » PMID: 23898196

Structural and Dynamic Studies of the Transcription Factor ERG Reveal DNA Binding is Allosterically Autoinhibited

Overview
Specialty Science
Date 2013 Jul 31
PMID 23898196
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The Ets-Related Gene (ERG) belongs to the Ets family of transcription factors and is critically important for maintenance of the hematopoietic stem cell population. A chromosomal translocation observed in the majority of human prostate cancers leads to the aberrant overexpression of ERG. We have identified regions flanking the ERG Ets domain responsible for autoinhibition of DNA binding and solved crystal structures of uninhibited, autoinhibited, and DNA-bound ERG. NMR-based measurements of backbone dynamics show that uninhibited ERG undergoes substantial dynamics on the millisecond-to-microsecond timescale but autoinhibited and DNA-bound ERG do not. We propose a mechanism whereby the allosteric basis of ERG autoinhibition is mediated predominantly by the regulation of Ets-domain dynamics with only modest structural changes.

Citing Articles

NMR investigation of FOXO4-DNA interaction for discriminating target and non-target DNA sequences.

Kang D, Yang M, Cheong H, Park C Commun Biol. 2024; 7(1):1425.

PMID: 39487330 PMC: 11530643. DOI: 10.1038/s42003-024-07133-1.


Erythroblastosis Transformation-Specific Regulated Gene 1 (ERG) Immunohistochemistry in the Diagnosis of Acute Myeloid Leukemia.

Lucas N, Neal C, Hsu B, Wright P Cureus. 2024; 16(5):e61168.

PMID: 38933637 PMC: 11202094. DOI: 10.7759/cureus.61168.


Nifuroxazide Activates the Parthanatos to Overcome TMPRSS2:ERG Fusion-Positive Prostate Cancer.

Li C, Zhang J, Wu Q, Kumar A, Pan G, Kelvin D Mol Cancer Ther. 2023; 22(3):306-316.

PMID: 36622760 PMC: 9978883. DOI: 10.1158/1535-7163.MCT-22-0159.


Allosteric interactions prime androgen receptor dimerization and activation.

Wasmuth E, Vanden Broeck A, LaClair J, Hoover E, Lawrence K, Paknejad N Mol Cell. 2022; 82(11):2021-2031.e5.

PMID: 35447082 PMC: 9177810. DOI: 10.1016/j.molcel.2022.03.035.


Past, Current, and Future Strategies to Target ERG Fusion-Positive Prostate Cancer.

Lorenzin F, Demichelis F Cancers (Basel). 2022; 14(5).

PMID: 35267426 PMC: 8909394. DOI: 10.3390/cancers14051118.


References
1.
Wei F, Zaprazna K, Wang J, Atchison M . PU.1 can recruit BCL6 to DNA to repress gene expression in germinal center B cells. Mol Cell Biol. 2009; 29(17):4612-22. PMC: 2725722. DOI: 10.1128/MCB.00234-09. View

2.
Hsu T, Trojanowska M, Watson D . Ets proteins in biological control and cancer. J Cell Biochem. 2004; 91(5):896-903. PMC: 2265084. DOI: 10.1002/jcb.20012. View

3.
Gangwar S, Dey S, Saxena A . Structural modeling and DNA binding autoinhibition analysis of Ergp55, a critical transcription factor in prostate cancer. PLoS One. 2012; 7(6):e39850. PMC: 3386182. DOI: 10.1371/journal.pone.0039850. View

4.
Babayeva N, Baranovskaya O, Tahirov T . Structural basis of Ets1 cooperative binding to widely separated sites on promoter DNA. PLoS One. 2012; 7(3):e33698. PMC: 3303851. DOI: 10.1371/journal.pone.0033698. View

5.
Emsley P, Cowtan K . Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004; 60(Pt 12 Pt 1):2126-32. DOI: 10.1107/S0907444904019158. View